An RA patient complains of ongoing joint pain and tenderness without swelling in multiple joints despite treatment with MTX and a biologic. CRP, ESR are normal. What would you do?
- D. Treat the pain (61%)
- C. Order a biomarker test (24%)
- A. Switch the biologic (11%)
- B. Switch the MTX (4%)
Start Date: March 21, 2016 @ 10:05 pm
End Date: No Expiry
An otherwise healthy 70-year-old female with GCA will receive high-dose prednisone (30–60 mg) over the next few months. Would you also start prophylactic antibiotic therapy?
- No (79%)
- Yes (21%)
Start Date: February 8, 2016 @ 12:54 pm
End Date: No Expiry
In view of the rising prominence of autoimmunity in the pathogenesis of a variety of non-rheumatologic diseases, should future rheumatologists be trained to co-manage some of these conditions?
- Yes (83%)
- No (17%)
Start Date: January 8, 2016 @ 12:02 pm
End Date: No Expiry
Looking back at some of the milestone achievements in rheumatology, which one is the most important?
- A. Use of TNFi (40%)
- B. Use of MTX (34%)
- D. Characterization of immunologic pathways (23%)
- C. MRI imaging of MSK (3%)
Start Date: December 9, 2015 @ 1:00 pm
End Date: No Expiry
A 40-year-old female patient with polymyositis has shown modest improvement following a four-week course of steroids and escalating doses of IM methotrexate (MTX). Her serum CK has dropped from 6100 I
- Stay the course—no changes (55%)
- Add rituximab (17%)
- Add IVIG (12%)
- Add MYC and maintain MTX (11%)
- Start mycophenolate (MYC) and withdraw MTX (5%)
Start Date: November 9, 2015 @ 11:17 am
End Date: No Expiry